Engineered Cyclotide Blocks Neuronal Excitotoxicity
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c01710 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Daryl Ariawan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Dementia Research Centre, Macquarie Medical School, Macquarie University 2109 Sydney, Australia. Hauptthemen laut MEDLINE: Neurons, Receptors, N-Methyl-D-Aspartate, Cyclotides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Health and Medical Research Council, Australian Research Council, Dementia Australia Research Foundation.
Abstract (Originalsprache)
Cyclotides are naturally occurring cyclic peptides with three disulfide bonds, offering remarkable stability. In neurological disorders, the formation of a complex between postsynaptic density protein 95 and NMDA receptors (NMDARs) can lead to neuronal cell death. In this study, we modified the MCoTI-II cyclotide backbone with polyarginines for enhanced intracellular delivery and grafted a 9-amino acid PSD-95-NMDAR inhibitor sequence, NR2B9c, into loop 6. We found that incorporating polyarginines into the cyclotide backbone significantly improved uptake into neuronal cells. Primary neurons treated with the NR2B9c cyclotide (c5R-NR2B9c) prevented cell death in response to high concentrations of N-methyl-d-aspartate (NMDA), demonstrating protection from excitotoxicity. Administration of c5R-NR2B9c in a chemically induced seizure model in mice resulted in increased survival and reduced seizure severity. Overall, we show that modifying cyclotides with a polyarginine backbone can enhance the delivery of therapeutic peptides into neuronal cells, which can be utilized to administer therapeutic peptides for the protection of neuronal cells from excitotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dementia Research Centre, Macquarie Medical School, Macquarie University 2109 Sydney, Australia.
ORCID-Profile: Daryl Ariawan, Sian Genoud, Thomas Fath
Förderung
- National Health and Medical Research Council
- Australian Research Council
- Dementia Australia Research Foundation
Zitieren
APA
Ariawan, D., van der Hoven, J., Morey, N., Pushpitha, K., Genoud, S., Stefen, H., Veltman, S., Przybyla, M., Deng, Y., Fath, T., Tietz, O., van Eersel, J., & Ittner, L. M. (2025). Engineered Cyclotide Blocks Neuronal Excitotoxicity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01710
Vancouver
Ariawan D, van der Hoven J, Morey N, Pushpitha K, Genoud S, Stefen H, et al. Engineered Cyclotide Blocks Neuronal Excitotoxicity. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c01710
BibTeX
@article{Ariawan2025,
author = {Ariawan, Daryl and van der Hoven, Julia and Morey, Nicolle and Pushpitha, Kanishka and Genoud, Sian and Stefen, Holly and Veltman, Sanne and Przybyla, Magdalena and Deng, Yuanyuan and Fath, Thomas and Tietz, Ole and van Eersel, Janet and Ittner, Lars Matthias},
title = {Engineered Cyclotide Blocks Neuronal Excitotoxicity},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c01710}
}
EUVIMED